the long-term body-composition outcomes rest more on user reports than on large human trials
Thats why scientists are investigating how these drugs might: Reduce cravings for drugs and alcohol Curb compulsive behaviors like gambling, overeating or excessive shopping Improve mood and emotional regulation Blunt dopamine spikes associated with addictive behaviors In animal studies, GLP-1 medications have shown promise in reducing self-administration of addictive substances like cocaine, alcohol and nicotine
Regulatory authorities are now encouraging industry stakeholders to adopt modern analytical tools (e.g., DNA barcoding, nuclear magnetic resonance (NMR) spectroscopy, and chemometrics) and post-market surveillance systems to track adverse events and ensure consumer safety
This might improve oral health and prevent some dental cavities and/or gum disease
The test identifies genetic predispositions in four critical areas: GLP-1 receptor sensitivity, glucose-dependent insulinotropic receptor (GIPR) function, melanocortin-4 receptor (MC4R) signaling, and fat mass and obesity-associated (FTO) gene variants